According to data from two phase III trials presented at this year's American Society of Clinical Oncology Genitourinary Cancers Symposium, patients with high-risk prostate cancer had a significantly ...

PURPOSE: Radical prostatectomy and external-beam radiation are the most common treatments for localized prostate cancer. Given the absence of clinical consensus in favor of one treatment or the other, ...

Salvage radical prostatectomy (RP) after radiation therapy is associated with increased risk of surgical complications relative to primary RP. Compared with primary radical prostatectomy (RP) for ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Adjuvant radiotherapy after radical prostatectomy provided no meaningful benefit in patients with prostate cancer but increased the risk for urinary and bowel morbidity compared with men followed with ...

Prostate cancer treatment options include radical prostatectomy, radiation therapy, and minimally invasive techniques like cryoablation, HIFU, and TULSA. Minimally invasive therapies generally have ...

Researchers found that stereotactic body radiotherapy (SBRT), a form of high-dose radiation delivered in just five sessions, is as safe as conventional treatment, with similar side effects and a ...

For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a vital role in reducing the risk of recurrence. Despite its benefits, many ...

A longitudinal study that tracked men over 10 years aims to provide patients with more information about their options following a diagnosis of prostate cancer. The study published Tuesday in the ...

Radical prostatectomy was not associated with clinically worse sexual function at 10 years, compared with active surveillance, EBRT, and brachytherapy. Radical prostatectomy for localized prostate ...

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...